CVB — Curvebeam AI Share Price
Last trade - 00:00- AU$38.74m
- AU$46.12m
- AU$6.53m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.95 | ||
| Price to Tang. Book | 10.76 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.9 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.61% | ||
| Return on Equity | -44.36% | ||
| Operating Margin | -246.09% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | n/a | 0.8 | 1.67 | 8.06 | 6.53 | 11.5 | 28.4 | 101.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Curvebeam AI Ltd is engaged in combining point-of-care diagnostic cone beam computed tomography (CT) imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI) expertise to deliver solutions across orthopedics and bone health (fragility fracture prevention). The Company’s orthopedic products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. Its systems can be utilized across multiple locations via a mobile imaging solution that is self-contained and easy to operate. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 23rd, 2009
- Public Since
- August 23rd, 2023
- No. of Shareholders
- 1,043
- No. of Employees
- 50
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 387,436,416
- Address
- 2800 Bronze Dr, Suite 110, HATFIELD, 19440
- Web
- https://curvebeamai.com/
- Phone
- +1 2674838081
- Auditors
- PricewaterhouseCoopers Securities Ltd
Upcoming Events for CVB
Similar to CVB
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
As of Today at 20:08 UTC, shares in Curvebeam AI are trading at AU$0.10. This share price information is delayed by 15 minutes.
Shares in Curvebeam AI last closed at AU$0.10 and the price had moved by -37.3% over the past 365 days. In terms of relative price strength the Curvebeam AI share price has underperformed the ASX All Ordinaries Index by -39.57% over the past year.
The overall consensus recommendation for Curvebeam AI is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCurvebeam AI does not currently pay a dividend.
Curvebeam AI does not currently pay a dividend.
Curvebeam AI does not currently pay a dividend.
To buy shares in Curvebeam AI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.10, shares in Curvebeam AI had a market capitalisation of AU$38.74m.
Here are the trading details for Curvebeam AI:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CVB
Based on an overall assessment of its quality, value and momentum Curvebeam AI is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Curvebeam AI is AU$0.18. That is 80% above the last closing price of AU$0.10.
Analysts covering Curvebeam AI currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Curvebeam AI. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -6.48%.
As of the last closing price of AU$0.10, shares in Curvebeam AI were trading -30.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Curvebeam AI PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Curvebeam AI's directors